“Achievement of On‑Treatment Remission With Risankizumab in Patients With Moderate‑to‑Severe Psoriasis”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s653. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/3791.